Type

FDA Approves New Drug to Treat Type I and Type II Diabetes

The Food and Drug Administration (FDA) today approved Symlin, an injectable medicine to control blood sugar for adults with type 1 and type 2 diabetes. Symlin is to be used in addition to insulin therapy in patients who cannot achieve adequate control of their blood sugars on intensive insulin therapy alone. Symlin will be the only therapy for the treatment of type 1 diabetes other than in...

Chemists identify key gene in development of type 1 diabetes

Chemists say they have identified a gene that appears to play a key role in the development of type 1 diabetes, also known as insulin-dependent or juvenile diabetes, a disease that affects about one million people in the U.S. and is on the rise worldwide. They described their findings, which they say could lead to new drug interventions and possibly gene therapy, today at the 229th national meeti...

First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes

Biologists at the University of Liverpool have discovered how the plagues of the Middle Ages have made around 10% of Europeans resistant to HIV. Scientists have known for some time that these individuals carry a genetic mutation (known as CCR5-delta32) that prevents the virus from entering the cells of the immune system but have been unable to account for the high levels of the gene in Scandinavi...

UCSD research reveals mechanism involved with type of fatal epilepsy

Researchers at University of California, San Diego (UCSD) have found that Lafora disease, an inherited form of epilepsy that results in death by the age of 30, can be caused by mutations in a gene that regulates the concentration of the protein laforin. These findings are reported in the current issue of Proceedings of the National Academy of Sciences (PNAS). Lafora disease is characterize...

Microarrays as phenotype

Microarrays provide a method of quantifying the expression and order of genes in a particular genome -- acting as a surrogate measure of cell physiology, said researchers at Baylor College of Medicine in a report that appears online today in the journal Nature Genetics. "Microarray data are good phenotypes to determine the order of genes and are a good surrogate measure of cell status," sa...

More>>

Type at Biology Products

Mouse Anti-Human Procollagen type I C-terminal propeptide (PICP) Monoclonal Antibody, Unconjugated from AntibodyShop A/S

Description:Procollagen type I C-terminal propeptide (human, PICP)...
Company:AntibodyShop A/S

Mouse Anti-Polio component type I Monoclonal Antibody, Unconjugated, Clone 9B4 from AntibodyShop A/S

Description:Polio component type I...
Company:AntibodyShop A/S

Rabbit Anti-Human Sirtuin (silent mating type information regulation 2, S.cerevisiae, homolog) 7 (SIRT7) Polyclonal Antibody, Unconjugated from Lifespan Biosciences

Description:Sirtuin 7 (SIRT7) Rabbit anti-Human Polyclonal Antibody Long term: -20C; Short term: +4C...
Company:Lifespan Biosciences

Human Topoisomerase I Wild Type from Calbiochem

Description:Liquid. In 100 mM KCl, 20 mM Tris-HCl, 1 mM DTT, 200 µM EDTA, 20% glycerol, pH 7.9. AVOID FREEZE/THAW CYCLES. Human DNA topoisomerase I (Topo I) is a monomeric protein of 765 amino acids encoded by a single-copy gene. It catalyzes the relaxation of both positive and negative supercoiled DNAs without the requirement of energy. In addition to DNA replication...
Company:Calbiochem

Buckets for 2 racks of 5 tubes, type Stago/Hitachi from Thermo Scientific

Description:Buckets for 2 racks of 5 tubes, type Stago/Hitachi...
Company:Thermo Scientific

More>>

Type at Biology Technology

Delivering siRNAs to Difficult Cell Types

Dmitriy Ovcharenko, Rich Jarvis, Kevin Kelnar, David Brown, Ambion, Inc. RNA interference (RNAi) is a powerful experimental tool for reducing the expression of specific genes. It...

Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae

Contributed by Alan T. Bakalinsky Department of Food Science and Technology, Oregon State University, Corvallis, OR 97331-6602 Chromosomal profiles of wine strains of Saccharomyces cerevisiae were compared to those of a standard laboratory karyotype. Qualitative analysis supported previous genetic...

Use of FlashPlate Technology for In Vitro Measurement of 125I-Labeled TGF-1 Binding on Chimeric Extracellular Domain of Type II Transforming Growth Factor Receptor

Dpartement dImmunologie, Laboratoires Fournier S.A., France TGF- type I and type II receptors form ligand dependent heteromeric signaling complexes, in which transforming growth factor- receptor type II (TRII) tends to act as the primary receptor....

Emerging game developer begins work on prototypes

Selling i...

Type at Biology Definition

Blood type

an...

Phenotype

, or by the identity of the <a href="/ ?q=/ Biolog...

Karyotype

is the complete set of all <a href="/ ?q=/ Bi...

Type at Biology Dictionary

Wild-type

al requirements depending upon the <a href="/ ?q=/ Biology-Dictionary/ species" cla...

Wildtype

W...

Wild type

<a...

Transformed phenotype

: Creation of an individual in which gen...

Phenotype

</ a...

More>>

Type at Medicine News

Prototype Detector detects Anthrax Quickly

A prototype handheld detector under development at Sandia National Laboratories can identify the fatty acid methyl esters (FAME) of anthrax in less than five minutes. //Sandia's Laboratory Directed Research and Development program supported the work. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin company, for the U.S. Department of Energy. Fatty a...

Periodontal disease may amass the risk of developing Type 2 diabetes

Study results from the Marquette University School of Dentistry suggest chronic periodontal disease may increase the risk of developing Type 2 diabetes.//The research ties the incidence of diabetes in patients with periodontal disease to the release of bacteria into the bloodstream that triggers a reaction from the immune system. Immune system cells can release proteins called cytok...

A way to slow the progression of Type 1 Diabetes

According to new research, a new drug that suppresses the immune system may slow the progression of type 1 diabetes. An early-phase clinical trial of 10 people aged 8 to 35 years with type 1 diabetes were treated with anti-CD3 mAb, a modified antibody.// A 14-day course of the drug appeared to slow the progressive decline in insulin production commonly seen in type 1 diabetics. Patient...

Celiac Disease in Type 1 Diabetes

According to researchers, a new study shows a strong connection between celiac disease and diabetes. American researchers report the prevalence of celiac disease in people with type 1 diabetes is about 25 times higher than in those without diabetes. Doctors have uncovered a new finding for diabetics.// Celiac disease is a condition in which the absorption of food nutrients through the...

Pancreas transplant gives hope to type 2 diabetes

A new hope for patients with type 2 diabetes. According to a new survey, they showed that a few patients with type 2 diabetes have been selected for a pancreas transplant.// Obesity is a strong risk factor for type 2 diabetes. In type 1 diabetes, the immune system destroys the insulin-producing cells of the pancreas. In type 2 diabetes, the body develops a resistance to insulin, usually...

More>>

Type at Medicine Products

Weil Type Swanson Design Hammertoe Implant

Description:For implantation in proximal interphalangeal joints of the lateral toes to correct deformity associated with degenerative or rheumatoid arthritis....
Company:Wright Medical Technology, Inc.

Self-Threading MONOKA (Fayet-Bernard Ritleng Type, PVP coating)

Description:This unique system uses prolene as thread-guide reducing time and trauma in lacrimal duct intubation. The hollow Ritleng Probe is inserted into the nasolacrimal duct and a thin prolene thread-guide is fed through it. The probe is then withdrawn leaving the polypropylene thread to pull the silicone tubing in place. Newly coated with a thin Polyvinylpyrrolidone (PVP) coating that makes the surface...
Company:FCI Ophthalmics Inc.

Self-Threading MONOKA (Fayet-Bernard Ritleng Type, 3 mm COLLARETTE)

Description:This unique system uses prolene as thread-guide reducing time and trauma in lacrimal duct intubation. The hollow Ritleng Probe is inserted into the nasolacrimal duct and a thin prolene thread-guide is fed through it. The probe is then withdrawn leaving the polypropylene thread to pull the silicone tubing in place. Canalicular Laceration or Imperforate Nasolacrimal Duct. Silicone, Blue Polyproylen...
Company:FCI Ophthalmics Inc.

Self-Threading MONOKA (Fayet-Bernard Ritleng Type, 4 mm COLLARETTE)

Description:This unique system uses prolene as thread-guide reducing time and trauma in lacrimal duct intubation. The hollow Ritleng Probe is inserted into the nasolacrimal duct and a thin prolene thread-guide is fed through it. The probe is then withdrawn leaving the polypropylene thread to pull the silicone tubing in place. Canalicular Laceration or Imperforate Nasolacrimal Duct. Silicone, Blue Polyproylen...
Company:FCI Ophthalmics Inc.

Jeweler Type Bipolar Insulated Forceps

Description:Straight shafts with micro tips and sandblast finish. Insulated smooth handle....
Company:Bausch & Lomb Storz

More>>

Type at Medicine Technology

Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types

Results also show significant additional protection againstinfection with virus types beyond 16 and 18 with the GSK cervicalcancer candidate vaccine PHILADELPHIA, June 27, 2007 /PRNewswire-FirstCall/ -- Resultsfrom an interim analysis of a Phase III study show thatCERVARIX(R), the GlaxoSmithKline cervical cancer candidate vaccine,provides up to 100 percent protection against advanced prec...

A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients

Final Results from Exploratory Phase IIa Clinical Trial in Type 2Diabetes Patients Announced TORONTO, June 28, 2007 /PRNewswire-FirstCall/ - TransitionTherapeutics Inc. ("Transition") , today announces the results fromits exploratory Phase IIa clinical trial indicating that 4-weeks ofdaily treatments with gastrin-based therapy, E1-I.N.T.(TM), showedsustained reductions in blood glucose co...

Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone

-- Additional Findings Reported Safety & Tolerability Profilein Subjects with Type 2 Diabetes and Healthy Subjects -- CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- Phase III datapresented this week at the annual meeting of the American DiabetesAssociation demonstrated that saxagliptin, an inhibitor ofdipeptidyl-peptidase-4 (DPP-4) in development by Bristol-MyersSquibb Company and A...

Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone

Additional Findings Reported Safety & Tolerability Profilein Subjects with Type 2 Diabetes and Healthy Subjects CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase III datapresented this week at the annual meeting of the American DiabetesAssociation demonstrated that saxagliptin, an inhibitor ofdipeptidyl-peptidase-4 (DPP-4) in development by Bristol-MyersSquibb Company (NYSE: BMY...

An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes

CHICAGO--(BUSINESS WIRE)--Jun 25, 2007 - New data from aninvestigational study released at the American Diabetes Association(ADA) 67th Annual Scientific Sessions showed that initialcombination therapy with Januvia(TM) (sitagliptin) and metformindemonstrated significant improvement in markers of beta cellfunction in patients with type 2 diabetes. Pancreatic islet betacell function determines...

More>>

Type at Medicine Dictionary

Type II diabetes

and may be delayed or controlled with <a href="/ ?q=/ Medicine-Dicti...

Type I diabetes

secrete the <a href="/ ?q=/ Medicine-Dictiona...

Type 2 diabetes

<A...